Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Grant of warrants

Company Announcement no. 28-2023 Today, the board of directors has exercised part of its current authorisation to issue a total of 186,000 warrants to the Company’s CFO and a key employee.The warrants are an essential part of securing long-term incentive for management in Donkey Republic to drive the ambitious growth plan and to ensure long-term value for all Donkey stakeholders. The CFO Christian Dufft has been granted 100,000 warrants and 86,000 warrants were granted to a key employee. Each warrant entitles the holder to subscribe for one share of nominally DKK 0.10 in Donkey

ABS Chairman and CEO Honors IMO Secretary General on Behalf of Shipping Industry

(DUBAI) ABS Chairman and Chief Executive Officer Christopher J. Wiernicki expressed the thanks of a grateful industry to IMO Secretary General Kitack Lim at the official gala dinner to mark the transition to his successor Arsenio Dominguez.   Speaking to more than 250 assembled leaders of the shipping industry at COP28, Wiernicki detailed Secretary General Lim’s “glittering legacy of achievement” and honored their shared commitment to safety.  “Consider the water under the bridge since January 1, 2016, when he took office. Think of the scale of change triggered by the

Transaction in Own Shares

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION 11 December 2023 REDDE NORTHGATE PLC (“Redde Northgate” or the “Group” or the “Company”)   Transaction in Own Shares   Redde Northgate plc (LSE:REDD) announces that on 11 December 2023 it purchased the following number of its own shares to be held in treasury:   Class of shares :  Ordinary shares of 50p (“shares”)

Buy-back of shares in Arise during week 49, 2023

During the period between 4 December and 8 December 2023 Arise AB (publ) (LEI code 549300FOT7EE85QYB655) (“Arise”) repurchased, in total, 120,578 own shares (ISIN code SE0002095604) under the share repurchase program initiated by the Board of Directors to deliver shareholder value and to optimize the capital structure of the company. The share buy-backs form a part of the share repurchase program of a maximum amount of SEK 100 million, which Arise announced on 14 November 2023. The share repurchase program, which runs from 16 November 2023 until the date of Arise's Annual General Meeting

EQT Infrastructure to acquire a majority position in Heritage Environmental Services, a leading provider of industrial waste management

· Industrial waste management services constitute a vital segment of the industrial manufacturing and production process by ensuring reliable and compliant final disposal of specialized and highly regulated waste · Transaction highlights EQT’s commitment to partnering with purpose-driven companies that provide essential services to society. Heritage Environmental Services owns and operates 37 mission critical assets that provide the last line of defense for the environment · EQT Infrastructure to accelerate Heritage’s future growth trajectory with EQT’s extensive experience in the

Slättö expands within public use real estate through acquisition of close to EUR 300 million portfolio from Estea

Slättö creates a new platform within public use real estate by acquiring a portfolio of properties concentrated in Stockholm and Gothenburg with an underlying value of approximately EUR 300 million.Slättö Core+ has today entered into a conditional agreement to acquire a public use portfolio with 47 properties totaling approximately 87,000 square meters from Estea Omsorgsfastigheter. The portfolio is located in large municipalities in Sweden with a focus around Stockholm and Gothenburg. It consists mainly of elderly care homes with a remaining lease duration of about 9 years. Slättö

Transactions carried out under Kongsberg Automotive’s share buy-back program

As announced on November 7, 2023 Kongsberg Automotive ASA (KA) has put in place a non-discretionary agreement with Danske Bank for the repurchase of up to 2.5% of its outstanding shares in the market. The share repurchases started on November 17, 2023. Date Aggregated Daily Weighted Total Volume (# of Average Price Transaction Shares) (NOK) Value(NOK)December 5, 2023 300,000 1.97 590,400December 6, 2023 300,000 1.99 596,340December 7, 2023 300,

Acquisitions of own shares in Evolution AB (publ)

Evolution AB (publ) (“Evolution”) has, during the period 4 December – 8 December acquired a total of 256,102 own shares within the framework of the repurchase programme introduced by the board of directors to improve the capital structure of Evolution by reducing the capital, and thereby creating added shareholder value.The repurchase programme, which Evolution announced on 23 November 2023, is being implemented in accordance with the EU Market Abuse Regulation No 596/2014 (“MAR”) and Commission Delegated Regulation No 2016/1052 (“Safe Harbour Regulation”). During the period 4 December –

Mandatory notification of trade - primary insiders

Multiconsult ASA (OSE: MULTI). As a part of the share purchase plan for employees in 2023, the following primary insiders have, on 11 December, bought the following number of shares in Multiconsult ASA (company):· Grethe Bergly, CEO, purchased 1 005 shares. After the transaction she holds 52 421 shares in the company. · Ove B. Haupberg, CFO, purchased 1 005 shares. After the transaction he holds 1 957 shares in the company. · Geir Juterud, EVP Projects, purchased 1 005 shares. After the transaction he holds 15 305 shares in the company. · Kari Nicolaisen, EVP HR & Corporate

#23-387 Delisting of Derivatives from NGM

Information about certain derivatives that will be delisted from NGM.For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for

#23-386 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for companies

Q-Free: Minutes of Extraordinary General Meetings on 11 December 2023

Two extraordinary general meetings in Q-Free ASA were held on 11 December 2023. All proposals on the agendas were adopted in accordance with the proposals from the board of directors, inter alia including an application for delisting of the company's shares from Oslo Børs and changes to the board of directors. The complete minutes of the extraordinary general meetings are attached to this release and available on www.q-free.com. This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act. For inquiries, please

Prostatype Genomics AB: Prostatype Genomics publishes prospectus due to upcoming preferential share issue

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, WHETHER DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, BELARUS OR ANY OTHER JURISDICTION WHERE SUCH DISTRIBUTION FURTHER REQUIRES PROSPECTUS, REGISTRATION, OR OTHER ACTIONS OTHER THAN THOSE UNDER SWEDISH LAW, ARE PROHIBITED, OR OTHERWISE CONTRARY TO APPLICABLE RULES IN SUCH JURISDICTION OR CANNOT TAKE PLACE WITHOUT APPLICATION OF EXCEPTIONS FROM SUCH ACTION. SEE THE "IMPORTANT INFORMATION" SECTION AT THE END OF THIS PRESS RELEASE.

Bioretec Ltd's schedule for financial reporting in 2024 and updates in the disclosure policy

Bioretec Ltd  Company announcement 11 December 2023 at 5:15 p.m. EETIn the future, in addition to the financial statements bulletin and half-year report, Bioretec will also publish business reviews for January–March and January–September. As a result, Bioretec Ltd has updated its disclosure policy describing the general principles and procedures that the company adheres to in its communication with capital markets and financial media.   The updated disclosure policy is available on the company’s web pages at https://bioretec.com/investors/investors-in-english/investor-relations/

Safello terminates services agreement with Finshark AB

Stockholm, 11 December 2023 | Safello, the leading cryptocurrency exchange in the Nordics, has terminated the agreement with Swedish payment service provider Finshark with immediate effect. The agreement was entered into on 11 July 2023 for the purpose of providing Safello with payment initiation services for instant payments and payouts, but the services have not been taken into active use.  ### For more information, please contactLouise Andersson, press@safello.com Certified AdviserAmudova AB is Safello’s certified adviser. Safello is the leading cryptocurrency exchange in

Observe Medical ASA - Exercise of subscription rights and over-subscription by primary insider and close associate of primary insider

Reference is made to the stock exchange announcement published by Observe Medical ASA (the "Company") on 27 November 2023 regarding the allocation of subscription rights (the "Subscription Rights") in the rights issue ("Rights Issue") to primary insiders and close associates. US Holding AS, a closely associated person of primary insider Rune Nystad which is CEO in the Company, has exercised 384,615 Subscription Rights, entitling US Holding AS to be allocated 384,615 offer shares in the Rights Issue at a price per offer share of NOK 0.26, subject to the Rights Issue being completed. For

Neste partners with Coleman Oil Company to make renewable diesel more widely available in Washington State

Neste Corporation, News, 11 December 2023 Photo: Coleman Oil truck in Washington State. Source: Coleman OilNeste has partnered with Coleman Oil Company, a leading provider of fuels, biofuels, lubricants, and related products, to enable cities and businesses to have easier access to Neste MY Renewable Diesel™  in the state of Washington in the U.S. This partnership expands the availability of Neste MY Renewable Diesel to key locations in Coleman Oil’s network of commercial fueling stations and other distribution channels, such as

Hamlet BioPharma is inviting you to join a digital presentation at Invest Live, Tuesday December 12[th] at 12.00 CET

Hamlet BioPharma, the innovative pharmaceutical company currently advancing several phase II trials targeting infectious diseases and cancer, along with an extensive project and patent portfolio, is delighted toinvite you to join a presentation at Invest Live, on Tuesday December 12[th]  at 12.00 CET. Gain insights into the company´s latest progress within its infectious disease and cancer therapy, which includes 'Fast Track' status for the company´s cancer-drug Alpha1H. We welcome share holders, investors and other interested parties to join the presentation and discussion. The

Calliditas Receives Notice of Allowance for United States Patent Application Covering TARPEYO®

Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) (“Calliditas”) today announced that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for patent application no. 18/100,396 entitled “New Pharmaceutical Compositions.”  This Notice of Allowance is expected to result in the issuance of a U.S. patent once administrative processes are completed.The allowed claims cover a method of treating IgA nephropathy with a composition that encompasses TARPEYO® (budesonide) delayed release capsules, developed under the name “NEFECON®”.

There are no items matching the current filter
There are no more items matching the current filter
Back to top